{"DataElement":{"publicId":"330","version":"8","preferredName":"Common Toxicity Criteria Adverse Event Grade","preferredDefinition":"the numeric indicator that describes the severity of an adverse event as defined in CTCAE.","longName":"CTC_AE_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188698","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Description","preferredDefinition":"information related to description or grade of a CTC adverse event.","longName":"CTC_AE_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177536","version":"1","preferredName":"Description ","preferredDefinition":"Description; a statement that represents something in words.","longName":"Description","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C1-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E53F9A78-2D9B-0D3F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2016876","version":"6","preferredName":"Adverse Event Grade","preferredDefinition":"a numeric indicator that describes the severity of an adverse event as defined in CTCAE v3.0 with a permissible value of 0 to 5.","longName":"AE_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[{"value":"5","valueDescription":"DEATH RELATED TO ADVERSE EVENT","ValueMeaning":{"publicId":"2562274","version":"1","preferredName":"DEATH RELATED TO ADVERSE EVENT","longName":"2562274","preferredDefinition":"The termination of life as a result of an adverse event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death Related to Adverse Event","conceptCode":"C48275","definition":"The termination of life associated with an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C04F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12D5-1125-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"0","valueDescription":"No adverse event or within normal limits","ValueMeaning":{"publicId":"2562273","version":"1","preferredName":"No adverse event or within normal limits","longName":"2562273","preferredDefinition":"NO ADVERSE EVENT OR WITHIN NORMAL LIMITS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C04E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"REEVESD","dateModified":"2009-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12D7-1125-E034-0003BA12F5E7","beginDate":"2002-11-14","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"MILD ADVERSE EVENT","ValueMeaning":{"publicId":"2575939","version":"1","preferredName":"MILD ADVERSE EVENT","longName":"2575939","preferredDefinition":"An experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild Adverse Event","conceptCode":"C41338","definition":"An experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12D9-1125-E034-0003BA12F5E7","beginDate":"2002-11-14","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"MODERATE ADVERSE EVENT","ValueMeaning":{"publicId":"2575940","version":"1","preferredName":"MODERATE ADVERSE EVENT","longName":"2575940","preferredDefinition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate Adverse Event","conceptCode":"C41339","definition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12DB-1125-E034-0003BA12F5E7","beginDate":"2002-04-16","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"SEVERE ADVERSE EVENT","ValueMeaning":{"publicId":"2575941","version":"1","preferredName":"SEVERE ADVERSE EVENT","longName":"2575941","preferredDefinition":"Severe adverse event is an experience that requires therapeutic intervention. The event interrupts usual daily activities. If hospitalization is required for treatment it becomes a serious adverse event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Adverse Event","conceptCode":"C41340","definition":"An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-17","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"FRAZIERP","dateModified":"2005-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12DD-1125-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"LIFE-THREATENING OR DISABLING ADVERSE EVENT","ValueMeaning":{"publicId":"2562276","version":"1","preferredName":"LIFE-THREATENING OR DISABLING ADVERSE EVENT","longName":"2562276","preferredDefinition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Life Threatening or Disabling Adverse Event","conceptCode":"C41337","definition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C051-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"CURTIST","dateModified":"2015-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12DF-1125-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAE:Common Terminology Criteria for Adverse Events v3.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2AF0537-12D1-1125-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-17","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"REEVESD","dateModified":"2009-09-23","changeDescription":"updated to meet criteria for CTCAE version 3.0","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"},{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"},{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"},{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"},{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811951","version":"1","longName":"Adverse Events","context":"CTEP"},{"publicId":"2812446","version":"1","longName":"Clinical Data Update System","context":"CTEP"},{"publicId":"2812383","version":"1","longName":"AdEERS","context":"CTEP"},{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812013","version":"1","longName":"Primary Brain New","context":"CTEP"},{"publicId":"2812014","version":"1","longName":"Primary Brain Recurr","context":"CTEP"},{"publicId":"2812015","version":"1","longName":"Metastatic Brain","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"},{"publicId":"2811884","version":"1","longName":"Adult STS New","context":"CTEP"},{"publicId":"2811885","version":"1","longName":"Adult STS Recurrent","context":"CTEP"},{"publicId":"2811886","version":"1","longName":"Ped STS New","context":"CTEP"},{"publicId":"10000027","version":"1","longName":"Bone Sarcoma New","context":"CTEP"},{"publicId":"10000028","version":"1","longName":"Bone Sarcoma Recur","context":"CTEP"},{"publicId":"2811889","version":"1","longName":"Ped STS Recurrent","context":"CTEP"},{"publicId":"10000449","version":"1","longName":"ALL Prev Untreated","context":"CTEP"},{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"},{"publicId":"2811786","version":"1","longName":"APL Prev Untreated","context":"CTEP"},{"publicId":"2811789","version":"1","longName":"Adjuvant Esophageal","context":"CTEP"},{"publicId":"2811790","version":"1","longName":"Adjuvant Gastric","context":"CTEP"},{"publicId":"2811792","version":"1","longName":"Advanced Esophageal","context":"CTEP"},{"publicId":"10000446","version":"1","longName":"Advanced Gastric","context":"CTEP"},{"publicId":"2811795","version":"1","longName":"CLL Prev Untreated","context":"CTEP"},{"publicId":"2811797","version":"1","longName":"CML Prev Untreated","context":"CTEP"},{"publicId":"2811802","version":"1","longName":"HCL Prev Untreated","context":"CTEP"},{"publicId":"2811806","version":"1","longName":"MDS Prev Untreated","context":"CTEP"},{"publicId":"2811810","version":"1","longName":"NSCLC 2nd Line","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811817","version":"1","longName":"Primary Cervical","context":"CTEP"},{"publicId":"2811818","version":"1","longName":"Primary Endometrial","context":"CTEP"},{"publicId":"2811819","version":"1","longName":"Primary Ovarian","context":"CTEP"},{"publicId":"2811821","version":"1","longName":"SCLC 2nd Line","context":"CTEP"},{"publicId":"2811822","version":"1","longName":"SCLC Extensive","context":"CTEP"},{"publicId":"2811823","version":"1","longName":"SCLC Limited","context":"CTEP"},{"publicId":"2811827","version":"1","longName":"Unresect Pancreatic","context":"CTEP"},{"publicId":"2811829","version":"1","longName":"Resect Pancreatic","context":"CTEP"},{"publicId":"2811915","version":"1","longName":"Adjuvant Colorectal","context":"CTEP"},{"publicId":"2811916","version":"1","longName":"Localized Prostate","context":"CTEP"},{"publicId":"2811918","version":"1","longName":"Advanced Colorectal","context":"CTEP"},{"publicId":"2811919","version":"1","longName":"Advanced Melanoma","context":"CTEP"},{"publicId":"2811920","version":"1","longName":"Non-local Prostate","context":"CTEP"},{"publicId":"2811921","version":"1","longName":"ALL Relapse/Refract","context":"CTEP"},{"publicId":"2811922","version":"1","longName":"AML Relapse/Refract","context":"CTEP"},{"publicId":"2811923","version":"1","longName":"APL Relapse/Refract","context":"CTEP"},{"publicId":"2811924","version":"1","longName":"CLL Relapse/Refract","context":"CTEP"},{"publicId":"2811925","version":"1","longName":"CML Relapse/Refract","context":"CTEP"},{"publicId":"2811926","version":"1","longName":"HCL Relapse/Refract","context":"CTEP"},{"publicId":"2811927","version":"1","longName":"Local-Reg Melanoma","context":"CTEP"},{"publicId":"2811928","version":"1","longName":"MDS Relapse/Refract","context":"CTEP"},{"publicId":"10000311","version":"1","longName":"Met/Urothelial","context":"CTEP"},{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"},{"publicId":"2811938","version":"1","longName":"Recurrent Gyn","context":"CTEP"},{"publicId":"10000312","version":"1","longName":"Superficial Bladder","context":"CTEP"},{"publicId":"10000369","version":"1","longName":"Curative Head/Neck","context":"CTEP"},{"publicId":"10000614","version":"1","longName":"Palliative Head/Neck","context":"CTEP"},{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"},{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"},{"publicId":"3298577","version":"1","longName":"Hepatobiliary","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"},{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812608","version":"1","longName":"Reporting Requirements","context":"NCIP"},{"publicId":"2812716","version":"1","longName":"EORTC SAE Report","context":"NCIP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"},{"publicId":"10000130","version":"1","longName":"Clinical Data Update System","context":"CTEP"},{"publicId":"2812619","version":"1","longName":"Patient Treatment by Course","context":"CTEP"},{"publicId":"10000210","version":"1","longName":"AdEERS","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000593","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104908","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"10000594","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4171063","version":"1","longName":"RTOG-0534","context":"NRG"},{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"},{"publicId":"4104879","version":"1","longName":"GOG-0219","context":"NRG"},{"publicId":"4104910","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"10000080","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"10000079","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"4104898","version":"1","longName":"GOG-0258","context":"NRG"},{"publicId":"10000590","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"10000589","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"4104914","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"},{"publicId":"4104995","version":"1","longName":"GOG-0269","context":"NRG"}]}],"AlternateNames":[{"name":"0002700","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0002514","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0001156","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0062778","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0061271","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0058373","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0064811","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0065132","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"20051070065132","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051060064811","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051050058373","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051040061271","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051030062778","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051020001156","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051010002514","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20051000002700","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"20050900000330","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"CTC_AE_GD","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CDUS_SOURCE","type":"DATA_ELEMENT_SOURCE","description":"Use CTC v2.0 or CTCAE v3.0 (as determined by CTEP) for reporting to Clinical Data Update System (CDUS) v3.0 Release 2","url":"http://ctep.cancer.gov/reporting/cdus.html","context":"CTEP"},{"name":"CTCAE_SOURCE","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","url":"http://ctep.cancer.gov/reporting/ctc.html","context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"CTC AE Grade","url":null,"context":"CTEP"},{"name":"CTC Adverse Event Grade","type":"Preferred Question Text","description":"CTC Adverse Event Grade","url":null,"context":"CTEP"},{"name":"-COMMENT","type":"COMMENT","description":"These values are used only when no specific AE grade is available. Data should be reported to CDUS using the correct CTCAE term and grade.","url":null,"context":"CTEP"},{"name":"COMMENT_226","type":"COMMENT","description":"For Phase III Treatment trials:  Only report Grade 4-5 for hematologic and Only report Grade 3-5 for non-hematologic","url":null,"context":"CTEP"},{"name":"EORTC SAE Form","type":"Alternate Question Text","description":"Severity (CTCAE)","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C2ADF9FC-D6AD-112B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-17","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"CHENR","dateModified":"2018-09-04","changeDescription":"updated to meet criteria for CTCAE version 3.0","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}